Should I Buy ILMN? ILMN 2026 Analysis

Should You Buy Illumina Inc (ILMN) Today? Analysis, Price Targets, and 2026 Outlook.

No data

Growth

Profitability

Efficiency

13 Analyst Rating

Wall Street analysts forecast ILMN stock price to fall

4 Buy

6 Hold

3 Sell

Hold

Current: 162.960

Low

40.5

Averages

133.54

High

170

Current: 162.960

Low

40.5

Averages

133.54

High

170

Guggenheim

Buy

maintain

$170 -> $180

AI Analysis

2026-06-01

New

Reason

Guggenheim

Price Target

$170 -> $180

AI Analysis

2026-06-01

New

maintain

Buy

Reason

Guggenheim raised the firm's price target on Illumina to $180 from $170 and keeps a Buy rating on the shares after having hosted the CFO and IR team for a series of investor meetings. The firm came away from the meetings firmer on Illumina's hold on the clinical sequencing market and views the company as poised for continued expansion from on-market assays and future investment, the analyst tells investors.

RBC Capital

initiated

$170

2026-05-14

Reason

RBC Capital

Price Target

$170

2026-05-14

initiated

Reason

RBC Capital resumed coverage of Illumina with an Outperform rating and $170 price target. The firm states that its constructive view on the stock is underpinned by building clinical momentum and fading competitive concerns. With clinical momentum building and competitive risks receding, the firm sees a favorable risk/reward for Illumina at current levels, RBC added.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ILMN

Unlock Now

ILMN Should I Buy

ILMN Should I Buy

Should You Buy Illumina Inc (ILMN) Today? Analysis, Price Targets, and 2026 Outlook.

No data

No data

Growth

Profitability

Efficiency

People Also Watch